Silk Road Medical Inc. (SILK) Tops Q4 EPS by 4c

Silk Road Medical Inc. (NASDAQ: SILK) reported Q4 EPS of ($0.34), $0.04 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $40.1 million versus the consensus estimate of $37.35 million.

For earnings history and earnings-related data on Silk Road Medical Inc. (SILK) click here.

You May Also Be Interested In

• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
• Greenlane Holdings Inc. (GNLN) reported Q2 result